Loading
Latest filing published 18 Sept 2026 for Knight Therapeutics Inc., €1,023. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Susan Caroline Emblem discloses dealings in Knight Therapeutics Inc. to SEDI. Between 15 June 2026 and 15 September 2026, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 18 September 2026: a share grant of €1,023, in Knight Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations